1. Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
   David Borg et al, 2018, Journal of Translational Medicine CrossRef
2. MiR-199a-5p-containing macrophage-derived extracellular vesicles inhibit SMARCA4 and alleviate atherosclerosis by reducing endothelial cell pyroptosis
   Weijie Liang et al, 2023, Cell Biology and Toxicology CrossRef
3. Overexpression of microRNA-5100 decreases the aggressive phenotype of pancreatic cancer cells by targeting PODXL
   YOSHIRO CHIJIIWA et al, 2016, International Journal of Oncology CrossRef
4. Podocalyxin influences malignant potential by controlling epithelial–mesenchymal transition in lung adenocarcinoma
   Hidenori Kusumoto et al, 2017, Cancer Science CrossRef
5. Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy
   Kimberly A Snyder et al, 2015, Breast Cancer Research CrossRef
6. Podocalyxin promotes glioblastoma multiforme cell invasion and proliferation by inhibiting angiotensin-(1-7)/Mas signaling
   BO LIU et al, 2015, Oncology Reports CrossRef
7. High Podocalyxin levels promote cell viability partially through up-regulation of Annexin A2
   Isabelle V. Leefa Chong San et al, 2016, Biochemical and Biophysical Research Communications CrossRef
8. Podocalyxin promotes cisplatin chemoresistance in osteosarcoma cells through phosphatidylinositide 3-kinase signaling
   ZHENG HUANG et al, 2015, Molecular Medicine Reports CrossRef
9. Angiopoietin-like 4 promotes melanoma cell invasion and survival through aldolase A
   YANG SUN et al, 2014, Oncology Letters CrossRef
10. Drug design targeting active posttranslational modification protein isoforms
    Fanwang Meng et al, 2021, Medicinal Research Reviews CrossRef
11. Emerging role of sperm-associated antigen 9 in tumorigenesis
    Jun Pan et al, 2018, Biomedicine & Pharmacotherapy CrossRef
12. Multifaceted role of RNA editing in promoting loss-of-function of PODXL in cancer
    Ting Fu et al, 2022, iScience CrossRef
13. MicroRNA-125b is involved in atherosclerosis obliterans in vitro by targeting podocalyxin
    XIAOBING LI et al, 2015, Molecular Medicine Reports CrossRef
14. A comparative transcriptomic analysis of astrocytes differentiation from human neural progenitor cells
    Marco Magistri et al, 2016, European Journal of Neuroscience CrossRef
15. Podocalyxin Promotes Glioblastoma Multiforme Cell Invasion and Proliferation via β-Catenin Signaling
    Yu Liu et al, 2014, PLoS ONE CrossRef
16. The cellular effects of novel triazine nitrogen mustards in glioblastoma LBC3, LN-18 and LN-229 cell lines
    Rafał Krętowski et al, 2019, Investigational New Drugs CrossRef
17. Podocalyxin-Like Protein Is Expressed in Glioblastoma Multiforme Stem-Like Cells and Is Associated with Poor Outcome
    Zev A. Binder et al, 2013, PLoS ONE CrossRef
18. Sperm-associated antigen 9 promotes astrocytoma cell invasion through the upregulation of podocalyxin
    JIAODE JIANG et al, 2014, Molecular Medicine Reports CrossRef
19. Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer
    Anna H. Larsson et al, 2016, Journal of Translational Medicine CrossRef
20. PODO447: a novel antibody to a tumor-restricted epitope on the cancer antigen podocalyxin
    Diana Canals Hernaez et al, 2020, Journal for ImmunoTherapy of Cancer CrossRef
21. Targeting a Tumor-Specific Epitope on Podocalyxin Increases Survival in Human Tumor Preclinical Models
    Diana Canals Hernaez et al, 2022, Frontiers in Oncology CrossRef
22. Emerging Role of Podocalyxin in the Progression of Mature B-Cell Non-Hodgkin Lymphoma
    Estíbaliz Tamayo-Orbegozo et al, 2020, Cancers CrossRef
23. Bmi1 Essentially Mediates Podocalyxin-Enhanced Cisplatin Chemoresistance in Oral Tongue Squamous Cell Carcinoma
    Yueying Zhou et al, 2015, PLOS ONE CrossRef